This appointment recognizes Dr. Syrmalis’s long-standing contribution to the biotechnology sector, where he has combined deep scientific expertise with strategic investment leadership. Through his role, Dr. Syrmalis will share his experience in biotechnology innovation, clinical research translation, and venture development to guide emerging biotech entrepreneurs in advancing their scientific and commercial goals.